Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,420 | 34,953 | 25,495 | 32,523 | 46,134 |
| Receivables | 68,324 | 69,478 | 66,650 | 63,426 | 63,745 |
| Other current assets | 30,063 | 27,947 | 23,140 | 20,154 | 19,959 |
| TOTAL | $138,065 | $137,394 | $122,246 | $125,701 | $135,153 |
| Non-Current Assets | |||||
| PPE Net | 2,005,299 | 1,979,382 | 1,864,790 | 1,832,800 | 1,807,560 |
| Investments And Advances | 246,450 | 199,994 | 90,643 | 77,036 | 80,582 |
| Intangibles | 23,517 | 23,950 | 24,383 | 24,816 | 25,485 |
| Other Non-Current Assets | 14,797 | 15,437 | 8,642 | 7,957 | 7,154 |
| TOTAL | $2,290,063 | $2,218,763 | $1,988,458 | $1,942,609 | $1,920,781 |
| Total Assets | $2,428,128 | $2,356,157 | $2,110,704 | $2,068,310 | $2,055,934 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 132,049 | 133,322 | 112,587 | 85,204 | 95,527 |
| Accounts payable and accrued liabilities | 102,091 | 200,619 | 79,831 | 67,475 | 46,088 |
| Accrued Expenses | 15,706 | 13,540 | 15,068 | 11,529 | 11,778 |
| TOTAL | $257,657 | $355,842 | $214,689 | $172,449 | $164,006 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,570,773 | 1,450,588 | 1,364,079 | 1,377,931 | 1,380,499 |
| Deferred Revenues | 7,811 | 8,361 | 7,203 | 8,241 | 10,613 |
| Other Non-Current Liabilities | 0 | 0 | 1,169 | 1,710 | 2,121 |
| TOTAL | $1,606,626 | $1,501,781 | $1,416,459 | $1,431,042 | $1,434,424 |
| Total Liabilities | $1,864,283 | $1,857,623 | $1,631,147 | $1,603,491 | $1,598,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,491 | 19,268 | 19,247 | 19,254 | 19,057 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 397,640 | 361,077 | 343,490 | 330,852 | 324,576 |
| Other shareholders' equity | -6,122 | -6,390 | -7,087 | -7,881 | -8,132 |
| TOTAL | $563,845 | $498,534 | $479,557 | $464,819 | $457,504 |
| Total Liabilities And Equity | $2,428,128 | $2,356,157 | $2,110,704 | $2,068,310 | $2,055,934 |